Bio-Works Technologies is a Swedish company that specializes in R&D, manufacturing, and supply of next-generation chromatography resins. With a richly experienced staff, the company is focused on the development and production of agarose-based products with exceptional performance for separating and purifying proteins and other biomolecules. Founded in 2006, Bio-Works operates at the forefront of the biotechnology and manufacturing industries from its headquarters in Uppsala, Sweden.
The company's commitment to sustainable development is evident through its adherence to ISO 9001:2015 standards and its active engagement in producing products that contribute to environmental sustainability. These innovative products cater to a wide range of applications in academic research laboratories, biopharmaceutical companies, and various other sectors.
Currently, Bio-Works has not disclosed its last investment or the involved investors, signaling a potential opportunity for venture capital firms seeking to support a promising player in the biotechnology and manufacturing sectors. The unique positioning, strong expertise, and commitment to innovation make Bio-Works an intriguing prospect for investors seeking to capitalize on the advancements in chromatography resins and sustainable biotechnology solutions.